By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Trulieve Cannabis Corp.

Trulieve Cannabis Corp. (TRLV)

NYSE Market Data in USD
$348.00
+$0.87
+0.25%
Last Update: 18 Jul 2026, 03:17
$0.00
Market Cap
P/E Ratio (TTM)
Forward Dividend Yield
$237.94-$473.63
52 Week Range

TRLV Stock Price Chart

Explore Trulieve Cannabis Corp. interactive price chart. Choose custom timeframes to analyze TRLV price movements and trends.

TRLV Company Profile

Discover essential business fundamentals and corporate details for Trulieve Cannabis Corp. (TRLV) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Pharmaceuticals

IPO Date

25 Sept 2018

Employees

5.00k

CEO

Kimberly A. Rivers

Description

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

TRLV Financial Timeline

Browse a chronological timeline of Trulieve Cannabis Corp. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 6 Aug 2026

EPS estimate is $0.09, while revenue estimate is $269.59m.

Earnings released on 7 May 2026

EPS came in at $0.01 surpassing the estimated -$0.01 by +170.82%, while revenue for the quarter reached $286.80m , beating expectations by +0.74%.

Earnings released on 26 Feb 2026

EPS came in at -$0.22 falling short of the estimated -$0.07 by -196.22%, while revenue for the quarter reached $293.10m , missing expectations by -1.75%.

Earnings released on 5 Nov 2025

EPS came in at -$0.14 falling short of the estimated -$0.08 by -65.52%, while revenue for the quarter reached $288.20m , beating expectations by +0.26%.

Earnings released on 6 Aug 2025

EPS came in at -$0.07 falling short of the estimated -$0.06 by -15.93%, while revenue for the quarter reached $302.10m , beating expectations by +0.21%.

Earnings released on 7 May 2025

EPS came in at -$0.17 falling short of the estimated -$0.07 by -131.67%, while revenue for the quarter reached $297.80m , beating expectations by +1.20%.

TRLV Stock Performance

Access detailed TRLV performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run